In: Journal of Psychopharmacology
Subjects: ANOREXIA COMORBIDADE TRANSTORNO OBSESSIVO-COMPULSIVO PSICOFARMACOLOGIA
ABNT
DINIZ, Juliana B.; COSTA, Daniel L. C.; CASSAB, Raony C. C.; et al. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, Thousand Oaks, n. 6, p. 603-611, 2014. Disponível em: < http://dx.doi.org/10.1016/j.tiv.2014.02.011 > DOI: 10.1016/j.tiv.2014.02.011.APA
Diniz, J. B., Costa, D. L. C., Cassab, R. C. C., Pereira, C. A. B., Miguel, E. C., & Shavitt, R. G. (2014). The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Journal of Psychopharmacology, ( 6), 603-611. doi:10.1016/j.tiv.2014.02.011NLM
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.Available from: http://dx.doi.org/10.1016/j.tiv.2014.02.011Vancouver
Diniz JB, Costa DLC, Cassab RCC, Pereira CAB, Miguel EC, Shavitt RG. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder [Internet]. Journal of Psychopharmacology. 2014 ;( 6): 603-611.Available from: http://dx.doi.org/10.1016/j.tiv.2014.02.011